checkAd
    Startseite > Aktien > GeNeuro porteur > Nachrichten
    GeNeuro porteur Aktie
    1,4925
     
    EUR
    +1,19 %
    +0,0175 EUR
    Letzter Kurs 08.05.24 Lang & Schwarz
    1,3850
     
    EUR
    684 STK
    Geldkurs 08.05.24
    1,6000
     
    EUR
    684 STK
    Briefkurs 08.05.24
    ISIN: CH0308403085 · WKN: A2AHDP · Schweiz

    Neueste Nachrichten

    GeNeuro Publishes its 2024 Universal Registration Document
    02.05.24 · Business Wire (engl.) · GeNeuro porteur
    GeNeuro Reports 2023 Full-Year Results and Provides Corporate Update
    30.04.24 · Business Wire (engl.) · GeNeuro porteur
    GeNeuro Announces Approval of all Resolutions Proposed at March 18, 2024, Extraordinary General Meeting
    20.03.24 · Business Wire (engl.) · GeNeuro porteur
    GeNeuro Announces a Successful €5 Million Private Placement
    02.02.24 · Business Wire (engl.) · GeNeuro porteur
    GeNeuro Launches an Offering With a Commitment to Subscribe by Existing Shareholders and Announces Its Cash Position at December 31, 2023
    01.02.24 · Business Wire (engl.) · GeNeuro porteur
    GeNeuro Names Anke Post as Chief Medical Officer, Following Retirement of David Leppert who Becomes a Consultant to GeNeuro
    05.01.24 · Business Wire (engl.) · GeNeuro porteur
    Independent Data Monitoring Committee Recommends Continuing the Trial Evaluating Temelimab in Long COVID Without Any Modifications
    11.12.23 · Business Wire (engl.) · GeNeuro porteur
    GeNeuro Announces Completion of Recruitment of Its Long-COVID Phase 2 Trial and Confirms Top-Line Results for June 2024
    28.11.23 · Business Wire (engl.) · GeNeuro porteur
    GeNeuro and Verily Collaborate to Advance Long-COVID Research
    19.10.23 · Business Wire (engl.) · GeNeuro porteur
    GeNeuro Reports 2023 Half-Year Results and Provides Corporate Update
    02.10.23 · Business Wire (engl.) · GeNeuro porteur
    New Study Published in PNAS Further Substantiates the Neuropathogenic Role of the HERV-W Protein in MS
    27.09.23 · Business Wire (engl.) · GeNeuro porteur
    GeNeuro: Recent Study Demonstrates the Strong Link Between SARS‑CoV‑2 Infection and HERV-W Activation in Hospitalized Psychotic Patients
    11.09.23 · Business Wire (engl.) · GeNeuro porteur